Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment

Gastroenterology

Volumn 141, Issue 5, 2011, Pages 1673-1679

  Talwalkar, Jayant A ^a   Swanson, Karen L ^a   Krowka, Michael J ^a   Andrews, James C ^a   Kamath, Patrick S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cardiac Output; Hemodynamics; Portal Hypertension; Vasodilators

Indexed keywords

BOSENTAN; PROSTACYCLIN; SILDENAFIL; UNIPROST;

ADULT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTOPULMONARY HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLENORENAL SHUNT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE;

EID: 80054860996     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.053     Document Type: Article

References (19)

1. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009; 54:543-554.
2. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplant candidates. Liver Transpl 2000;6:453-458. (Pubitemid 30489119)
3. Cotton CL, Gandhi S, Vaitkus PT, et al. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl 2002;8:1051-1054. (Pubitemid 35363632)
4. Krowka MJ, Swanson KL, Frantz RP, et al. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006;44:1502-1510. (Pubitemid 44953655)
5. Swanson KL, Wiesner RH, Nyberg SL, et al. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant 2008;8:2445-2453.
6. Krowka MJ, Plevak DJ, Findlay JF, et al. Pulmonary hemodynamics and perioperative cardiopulmonary related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443-450. (Pubitemid 30489117)
7. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174-182. (Pubitemid 38240114)
8. Passarella M, Fallon MB, Kawut SM. Portopulmonary hypertension. Clin Liver Dis 2006;10:653-663. (Pubitemid 44879988)
9. Edwards BS, Weir EK, Edwards WD, et al. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 1987;10:1233-1288.
10. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43(Suppl S):25S-32S. (Pubitemid 38759714)
11. Ridaura-Sanz C, Mejia-Hernandez C, Lopez-Corella E. Portopulmonary hypertension in children. A study in pediatric autopsies. Arch Med Res 2009;40:635-639.
12. Hadengue A, Benhayoun MK, Lebrec D, et al. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991;100:520-528.
13. Huonker M, Schumacher YO, Ochs A, et al. Cardiac function and hemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44:743-748. (Pubitemid 29195928)
14. Rodriguez-Roisin R, Krowka MJ, Herve P, et al. Pulmonary-hepatic vascular disorders: a task force report. Eur Respir J 2004;24: 861-880. (Pubitemid 39504442)
15. Colle IO, Morean R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology 2003;37:401-409. (Pubitemid 36152540)
16. Swanson KL, Krowka MJ. Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleveland Clin J Med 2008;75:121-136.
17. Kawut SM, Krowka MJ, Trotter JF, et al. Clinical risk factors for portopulmonary hypertension. Hepatology 2008;48:196-203. (Pubitemid 351975544)
18. LePavee J, Souza R, Herve P, et al. Portopulmonary hypertension: survival and prognostic factors. Am J Resp Crit Care Med 2008; 178:637-643.
19. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470. (Pubitemid 32119037)